Rology is a technology company.
Rology has raised $860K across 1 funding round.
Rology has raised $860K in total across 1 funding round.
Rology is an Egypt-based healthtech company founded in 2017 that builds an AI-assisted teleradiology platform connecting hospitals worldwide with remote subspecialized radiologists to address radiologist shortages and reduce report turnaround times.[1][2][4] The platform serves over 300 hospitals across 13 countries in the Middle East and Africa, delivering more than 1.3 million reports with 99.89% clinical accuracy, supporting 12 subspecialties and 8 imaging modalities, and enabling results in as little as 30 minutes at zero setup cost.[2][3][6] It has demonstrated strong growth momentum, including FDA 510(k) clearance as a Class II medical image management system, acquisition of Saudi provider Arkan United in 2023, and a recent growth funding round from investors like Philips Foundation, Johnson & Johnson Impact Ventures, Sanofi Global Health Unit’s Impact Fund, and MIT Solve.[1][2][6]
Rology was launched in October 2017 in Cairo, Egypt, by founders Amr Abodraiaa (CEO), Moaaz Hossam (Chief Business Officer), Mahmoud Eldefrawy (Chief Medical Officer), and Bassam Khallaf, who identified the critical gap in radiology access amid global shortages of specialists.[2][5][6] The idea emerged to create a cloud-based platform matching hospitals with remote radiologists using laptops and internet, bypassing infrastructure barriers and enabling subspecialty reporting with quality controls.[1][4][6] Early traction included rapid adoption in underserved regions, pre-Series A funding in 2022, expansion into Saudi Arabia via the Arkan United acquisition in 2023, and FDA clearance in collaboration with Innolitics, solidifying its role in fragile healthcare systems.[1][3][6]
Rology rides the AI-driven teleradiology wave amid global radiologist shortages, particularly in the Middle East and Africa, where healthcare infrastructure lags and demand surges from aging populations and chronic diseases.[1][2][7] Timing aligns with regulatory wins like FDA clearance and regional expansions (e.g., Saudi Arabia, Kenya), fueled by market forces such as digital health adoption post-COVID, AI advancements in multimodal imaging, and impact investing in underserved regions.[1][2][6] It influences the ecosystem by democratizing diagnostics via platformization and decentralization, enabling on-demand global radiologist networks, reducing latency/costs, and integrating with public health systems like Africa CDC, positioning it as critical infrastructure for equitable care.[3][6][7]
Rology is primed for explosive growth, leveraging its recent funding to scale AI tools, deepen MEA penetration (e.g., Kenya, Saudi Arabia), and expand globally as the premier FDA-cleared teleradiology leader.[2][6] Trends like agentic AI, foundation models, and telehealth mandates will amplify its edge, potentially doubling report volumes amid rising demand in fragile states. Its influence may evolve into a full radiology-as-a-service backbone, bridging urban-rural divides and saving millions more lives, fulfilling its founding promise of instant, high-quality access.[2][3]
Rology has raised $860K in total across 1 funding round.
Rology's investors include Asia Africa Investment & Consulting (AAIC).
Rology has raised $860K across 1 funding round. Most recently, it raised $860K Seed in September 2020.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Sep 1, 2020 | $860K Seed | Asia Africa Investment & Consulting (AAIC) |